An automatic skin lesion segmentation system with hybrid FCN-ResAlexNet
Sezin Barın, Gür Emre Güraksın
Engineering Science and Technology, an International Journal · 2022
doi:10.1016/j.jestch.2022.101174 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Skin cancer is a serious global health concern with high morbidity and mortality rates. Therefore, computer-aided automatic diagnostic systems are essential to diagnose skin lesions successfully. One of the most important ways to achieve that is the segmentation of skin lesions. This study compared different criteria used to improve the performance of lesion segmentation in skin images via deep Convolutional Neural Network (CNN) architectures. In addition, for the segmentation of skin lesions, a new hybrid FCN (Fully Convolutional Network)-based deep learning architecture is proposed, in which AlexNet and ResNet18 deep learning architectures are used in the encoder structure, and three deconvolution layers are included in the decoder part. In the study, ISIC2017 and ISIC2018 data sets, the most used in the segmentation of skin lesions, were used. Results show that the proposed architecture, FCN-ResAlexNet, trained with the ISIC2017 data set, provided 0.35%, 2.73%, and 4.2% higher performance than the FCN-AlexNet architecture in accuracy, dice, and Jaccard index performance metrics, respectively. Also, The FCN-ResAlexNet architecture trained with the ISIC2018 dataset provided 1.79%, 0.95%, and 1.5% higher performance than the FCN-AlexNet architecture in accuracy, dice, and Jaccard index performance metrics, respectively.
Abstract licence: CC BY-NC-ND
References70
- 20.
- 31.
38 more references, whose wording the paper’s licence keeps private.
All 70 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.